- Home
- RCON vs ENTX Comparison
RCON vs ENTX Comparison
Compare RCON & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCON
- ENTX
- Stock Information
- Founded
- RCON 2007
- ENTX 2010
- Country
- RCON China
- ENTX Israel
- Employees
- RCON N/A
- ENTX N/A
- Industry
- RCON Oilfield Services/Equipment
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RCON Energy
- ENTX Health Care
- Exchange
- RCON Nasdaq
- ENTX Nasdaq
- Market Cap
- RCON 86.1M
- ENTX 86.3M
- IPO Year
- RCON 2009
- ENTX 2018
- Fundamental
- Price
- RCON $2.24
- ENTX $2.00
- Analyst Decision
- RCON
- ENTX Strong Buy
- Analyst Count
- RCON 0
- ENTX 1
- Target Price
- RCON N/A
- ENTX $10.00
- AVG Volume (30 Days)
- RCON 176.0K
- ENTX 63.0K
- Earning Date
- RCON 09-26-2025
- ENTX 08-08-2025
- Dividend Yield
- RCON N/A
- ENTX N/A
- EPS Growth
- RCON N/A
- ENTX N/A
- EPS
- RCON N/A
- ENTX N/A
- Revenue
- RCON $8,996,572.00
- ENTX $166,000.00
- Revenue This Year
- RCON N/A
- ENTX N/A
- Revenue Next Year
- RCON $12.17
- ENTX N/A
- P/E Ratio
- RCON N/A
- ENTX N/A
- Revenue Growth
- RCON N/A
- ENTX 191.23
- 52 Week Low
- RCON $1.40
- ENTX $1.50
- 52 Week High
- RCON $7.16
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- RCON 43.35
- ENTX 54.61
- Support Level
- RCON $2.15
- ENTX $1.94
- Resistance Level
- RCON $2.44
- ENTX $2.01
- Average True Range (ATR)
- RCON 0.28
- ENTX 0.07
- MACD
- RCON -0.05
- ENTX 0.01
- Stochastic Oscillator
- RCON 19.37
- ENTX 86.96
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.